drugset / Trial / NCT03870490
Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects
Phase 1
Completed
20 enrolled
Venatorx Pharmaceuticals, Inc.
National Institutes of Health (NIH) · collab
NaSingle-groupOpen-labelBasic science
Summary
This is a single-center, open-label study to assess safety and pharmacokinetics of VNRX-5133 and cefepime in the epithelial lining fluid in healthy adult male and female subjects.
Timeline
- Start
- 2019-03-14
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cefepime | Small molecule | — | Intravenous |
| Subject | taniborbactam | Other / unclassified | — | Intravenous |
Indications
No indication recorded.